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Abstract: Kikuchi’s disease is a benign condition that occurs in women. A young woman presented to the hospital with fevers and cer-
vical lymphadenopathy. Infectious work-up was negative except for streptococcus pharyngitis. Imaging studies revealed the presence 
of diffuse cervical and axillary lymphadenopathy. The fevers persisted and she underwent excisional cervical lymph node biopsy that 
revealed histiocytic necrotizing lymphadenitis corresponding to a benign diagnosis of Kikuchi’s disease. Three months later, the patient   
was afebrile and there was complete resolution of the cervical lymphadenopathy. 
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Introduction
Kikuchi’s  disease  is  a  rare  and  benign  condition 
described  in  young  women.  It  is  characterized  by 
  cervical lymphadenopathy and fever and is often mis-
taken for more serious conditions. We describe a case 
of a young woman who presented with fever, malaise 
and diffuse cervical lymphadenopathy.
case presentation
A 29-year-old healthy woman presented to the emer-
gency department with complaints of fever, chills and 
malaise for one week. She had been taking ibuprofen 
at home with no relief. She also noticed swelling in 
her neck bilaterally. There was no history of recent 
travel, sick contacts or exposure to people with tuber-
culosis. She denied dysuria, cough, diarrhea, short-
ness of breath, chest pain, menorraghia, night sweats 
or weight loss. She has been in a monogamous rela-
tionship for many years. There was no family history 
of lymphoma, leukemia, systemic lupus erythemato-
sus, rheumatoid arthritis or any other rheumatologic 
disorders. She did not take any prescription or herbal 
medications. Social history was negative. Vital signs 
in the emergency department revealed a temperature 
of 103.2 F and a pulse of 113. Physical exam was nor-
mal except for bilateral anterior and posterior cervi-
cal, pre and post-auricular, submandibular, submental 
and right axillary lymphadenopathy. Initial laboratory 
studies revealed white blood cell count-3000 th/mm3, 
hemoglobin-8.8 g/dL, platelets-273 th/mm3 and mean 
corpuscular volume-66.2 mcm3. Chest x-ray was nor-
mal. Subsequently, she was admitted to the inpatient 
floor  with  persistent  fevers  and    lymphadenopathy. 
Further  laboratory  studies  revealed  anemia  of 
chronic  disease.    Hemolytic  work-up  was  negative. 
  Hemoglobin  electrophoresis  revealed  no  evidence 
of β thalessemia. HIV, EBV monospot, Toxoplasma, 
and CMV serologies were negative. The patient con-
tinued to experience high fevers with rapidly increas-
ing diffuse lymphadenopathy and further laboratory 
testing was ordered. Peripheral blood flow cytometry 
revealed no monoclonal B cell population that was 
identified and no evidence of paroxysmal nocturnal 
hemoglobinuria. The throat culture revealed β hemo-
lytic streptococcus and she was prescribed penicillin. 
CT scans of the chest, and abdomen/pelvis with intra-
venous contrast revealed enlarged bilateral axillary 
lymphadenopathy   measuring up to 2.7 cm in largest 
dimensions. CT scan of the neck with intravenous 
contrast  showed  diffuse  enhancing  lymphadenopa-
thy involving all neck levels, soft tissues and axil-
lae bilaterally.   Surgery consultation was obtained for 
the consideration of an excision lymph node biopsy. 
Further laboratory studies revealed an elevated IgG 
level. Antinuclear antibody and anti-double stranded 
DNA testing were negative. β2 microglobulin level 
was elevated. Angiotensin-converting enzyme level 
was normal. She underwent excisional lymph node 
biopsy of the left cervical lymph node and was dis-
charged home with instructions to take acetamino-
phen if she had recurrent fevers. The pathology report 
of  the  lymph  node  revealed  lymphoid  tissue  with 
extensive  geographic  necrosis  (necrotizing  histio-
cytic inflammation) suggestive of Kikuchi’s disease 
(Fig. 1). There was no evidence of infection in the 
lymph node specimen. The patient was informed of 
the diagnosis and told to return to the outpatient clinic 
for follow-up evaluation.
One month later, the patient presented to the out-
patient clinic. The fevers had resolved and the lymph 
nodes had markedly reduced in size to less than a centi-
meter clinically. The hemoglobin was improving. She 
had further work-up to search for an identifiable cause 
of her condition. Serologic testing for human herpes 
virus 6, human herpes virus 8, and respiratory virus 
panel were negative except for an elevated parvovi-
rus IgG level. Repeat HIV testing was also   negative. 
She  was  also  referred  to  the  rheumatology  clinic 
because she began experiencing morning stiffness. 
On a three month follow-up visit, she continued to   
Figure  1.  Low  magnification  view  showing  necrotizing  histiocytic 
inflammationA benign cause of fever and lymphadenopathy
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be   afebrile and the lymphadenopathy and microcytic 
anemia had resolved. Although the microcytic   anemia 
had resolved, she was recommended to undergo a 
colonoscopy  and  upper  endoscopy  to  evaluate  the 
  etiology of the microcytic anemia. Laboratory testing 
done in the rheumatology clinic revealed no evidence 
of any rheumatologic conditions.
Discussion
Kikuchi’s  disease  also  referred  to  as  Kikuchi-
  Fujimoto disease and Kikuchi’s histiocytic necrotiz-
ing lymphadenitis is a rare and benign condition that 
has been mainly described in women younger than 
40 years of age. It has been described in all ethnic 
groups. Although it mainly affects woman, it has also 
been described in men. It can mimic serious condi-
tions like lymphoproliferative disorders and tubercu-
losis lymphadenitis. There have only been a few case 
reports described in the literature.
The pathogenesis of Kikuchi’s disease is not clear. 
It is believed that there is an immune response of the 
T cells and histiocytes to an inciting agent. Numerous 
pathogens have been described including Epstein Barr   
virus,1 human herpes virus 6 and 8,2 human immuno-
deficiency virus, toxoplasma, yersenia enterocolitica, 
parvovirus,3 parainfluenza and paramyxoviruses. It 
is thought that cellular destruction is due to apoptotic 
cell death that is mediated by CD8 T lymphocytes.4
Kikuchi’s disease usually presents with fever and 
cervical lymphadenopathy in a young healthy woman. 
Fever is the most prominent symptom and can persist 
for a week. Patients can also present with systemic 
signs and symptoms such as night sweats, weight loss, 
diarrhea, rash, and arthritis.   Lymphadenopathy is pres-
ent universally in all the patients. Rash that is similar 
to drug-induced lupus or rubella can be seen in some 
patients.5 Lymphadenopathy is usually localized and 
involves the cervical lymph nodes but there may be 
involvement of the axillary, mediastinal, iliac, intrapa-
rotid, retrocrural, peripancreatic and celiac nodes. The 
nodes are firm, smooth, mobile and about 1–2 cm in 
size and patients may often experience pain associated 
with  nodal  enlargement.    Neurological  symptoms 
such as ataxia, tremors and aseptic meningitis have 
also  been  described  in  some  patients.6,7  Anemia, 
leukopenia,  elevated  immunoglobulin  levels,  and 
elevated erythrocyte sedimentation rate can be seen 
in the laboratory studies.1 Bone marrow examination 
can reveal an increase in macrophages without atypi-
cal  cells.8  Antinuclear  antibodies  and  rheumatoid 
  factor are generally negative. However some patients 
diagnosed with Kikuchi’s disease can develop auto-
immune disorders.9
Differential  diagnoses  for  Kikuchi’s  disease 
include  lymphoma,  tuberculous  adenitis,  lym-
phogranuloma  venereum  and  Kawasaki  disease. 
CT scans of the neck and chest will show diffuse 
enhancing   lymphadenopathy. Lymph node biopsy is 
the definitive way to make the diagnosis of Kikuchi’s 
disease. Biopsy should be done to exclude serious 
disorders like   lymphoma. Patients have been misdi-
agnosed as having lymphoma and have been treated 
with   chemotherapy.9 The histology of the lymph node 
in Kikuchi’s disease is unique and can be differenti-
ated from other infectious causes of lymphadenopa-
thy except in systemic lupus eythematosus.9 Necrotic 
foci can be seen on gross examination. Paracortical 
foci with histiocytic infiltrate are seen on microscopic 
examination.  The  histological  appearance  of  the 
lymph node can vary according to progression of the 
disease. The proliferative phase can show the pres-
ence of follicular hyperplasia with T and B blast cells 
that can be confused for lymphoma. The necrotizing 
phase can show necrosis with histiocytes. Immunohis-
tochemical stains will be positive for CD68 plasma-
cytoid monocytes and histiocytes with predominantly 
CD8 T lymphocytes.
There  is  no  effective  treatment  for  Kikuchi’s 
  disease. The signs and symptoms typically resolve in 
Figure  2.  oil  immersion  view  showing  histiocytes  and  plasmacytoid 
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one to four months. High dose glucocorticoids with 
intravenous  immunoglobulin  have  been  shown  to 
have some benefit in severe symptoms.10 Kikuchi’s 
disease is self-limited but the patients should be fol-
lowed for a few years since recurrence is common 
and some of the patients can develop systemic lupus 
erythematosus.
conclusion
Although Kikuchi’s disease is a rare entity, we should 
consider it in the differential diagnosis when a young 
woman presents with fever and cervical lymphade-
nopathy.  Accurate  diagnosis  of  this  condition  is 
essential  in  preventing  unnecessary  emotional  and 
mental distress associated with labeling a patient as 
having a more serious condition such as lymphoma 
or   systemic lupus erythematosus.
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